UNSPSC 51332859: Mesoridazine besylate

This classification denotes a dopamine antagonist and antipsychotic agent, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier T4G2I958J2. European Medicines Agency schedules Mesoridazine besilate in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB03180MIG. Mesoridazine besylate generally arises in the molecular formula C21H26N2OS2.C6H6O3S. The term 'mesoridazine besylate' is a U.S. Pharmacopeial Convention designation.

Most nations, for tariff and trade purposes, schedule mesoridazine besylate under HS 29343090. As of Q4 2014, MESORIDAZINE BESYLATE remains US FDA's Preferred Term for this commodity. Mesoridazine besylate bears US NLM identifiers UMLS ID C0700543 and NCI Concept Code C66101. SMILES: CN1CCCCC1CCN2C3CCCCC3SC4C2CC(CC4)[S+](C)[O-].C1CCC(CC1)S(=O)(=O)O.

UNSPSC 51332859 Mesoridazine besylate is a Commodity code that nominally addresses a specific antipsychotic pharmaceutical, but the recent state and local procurement activity tagged under this code does not align with that narrow scope. Instead, the single recent opportunity on file—Seminole County, Florida's IFB for Naloxone & Drug Deactivation Systems—reflects acquisition of emergency-response pharmaceuticals and harm-reduction equipment rather than antipsychotic medication. State and local health departments and county public-health agencies appear to be the primary issuing bodies under this code, though the limited recent activity makes broad characterization difficult. The work being solicited centers on community health and emergency-response supplies, including naloxone kits and drug deactivation systems, procured through competitive bidding with requirements for quarterly delivery, E-Verify compliance, drug-free workplace certification, and standard commercial insurance coverage.

Seminole County, Florida represents the only recent opportunity in the source. The county issued IFB 60459723LAS on June 30, 2026, seeking 1,900 units of Naloxone and 800 Safe Drug Deactivation Systems annually, with a response deadline of July 26, 2023, and quarterly deliveries to the Seminole County Community Health Building at 520 West Lake Mary Boulevard, Sanford. Vendors must include all shipping and delivery costs in their proposals and submit bids electronically through the county's e-Procurement Portal. The initial contract term runs two years with an optional one-year renewal, and the procurement is potentially funded through FEMA, introducing compliance obligations under the Clean Air Act and Federal Water Pollution Control Act. The code shows limited recent activity; the mismatch between the code's nominal pharmaceutical scope and the actual acquisitions being procured suggests either tagging inconsistency or that this Commodity code is not a primary vehicle for state and local pharmaceutical procurement.